New classes of anticoagulation and antiplatelet agents: preprocedure management and safety guidelines for imaging-guided intervention.
OBJECTIVE
New medications are available for prophylaxis of deep venous thrombosis, the treatment of venous thromboembolism, and also to reduce the risk of acute coronary syndrome and stroke. The purpose of this review is to provide the radiologist a practical and succinct summary of the new anticoagulation and antiplatelet medications and how to manage these medications in patients who are in need of a radiology intervention.


CONCLUSIONS
This article provides recommendations for preprocedure management of new anticoagulants and antiplatelet agents in patients undergoing radiology intervention.
Department of Radiology, Duke University Medical Center, Durham, NC 27710, USA. lisaho@duke.edu
Lisa M
LM
Ho
Kimberly L
KL
Hodulik
Paul V
PV
Suhocki
Lynne M
LM
Hurwitz
Erik K
EK
Paulson
D054058:Acute Coronary Syndrome / Q000517:prevention & control; D000925:Anticoagulants; D003952:Diagnostic Imaging; D006801:Humans; D010975:Platelet Aggregation Inhibitors; D020521:Stroke / Q000517:prevention & control; D013923:Thromboembolism / Q000188:drug therapy; D020246:Venous Thrombosis / Q000517:prevention & control
D000925:Anticoagulants; D010975:Platelet Aggregation Inhibitors